Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -13.76%26.85M | -10.21%27.38M | -6.04%118.65M | -28.21%27.23M | 0.76%29.85M | 4.87%31.13M | 6.34%30.5M | 0.06%126.27M | 30.94%37.93M | 2.59%29.62M |
| Cost of revenue | 0.34%28.95M | -11.24%28.85M | ||||||||
| Gross profit | -7.93%89.69M | 3.98%97.41M | ||||||||
| Operating expense | -11.23%27.31M | -5.74%28.08M | 14.57%4.67M | -15.72%30.41M | 3.69%29.68M | 3.62%30.77M | 2.63%29.79M | -95.52%4.07M | 1,071.81%36.08M | -0.04%28.63M |
| Staff costs | ---- | ---- | 1.57%7.59M | ---- | ---- | ---- | ---- | --7.47M | ---- | ---- |
| Other operating expenses | -11.21%28.15M | -6.10%28.51M | -2.68%123.74M | -16.83%30.82M | 4.13%30.85M | 2.45%31.7M | 2.85%30.36M | 37.68%127.15M | 627.49%37.06M | -3.26%29.63M |
| Total other operating income | -10.37%838K | -25.00%432K | -14.02%2.92M | -57.89%411K | 16.52%1.17M | -25.44%935K | 15.90%576K | 162.31%3.4M | 129.47%976K | -49.52%1.01M |
| Operating profit | -225.96%-461K | -198.59%-697K | -8.91%85.02M | -272.47%-3.18M | -83.43%165K | 12,300.00%366K | 303.75%707K | 3,456.67%93.34M | 995.89%1.85M | 320.25%996K |
| Net non-operating interest income (expenses) | 7.65%-326K | 7.00%-332K | 11.42%-1.33M | 57.60%-307K | 11.81%-336K | 8.55%-353K | 13.14%-357K | 12.88%-1.51M | -85.09%-724K | 11.81%-381K |
| Non-operating interest expense | -7.65%326K | -7.00%332K | -11.42%1.33M | -57.60%307K | -11.81%336K | -8.55%353K | -13.14%357K | -12.88%1.51M | 85.09%724K | -11.81%381K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 18.58%536K | -13.45%193K | 102.31%71.43K | 86.28%-500K | 12.96%279K | 242.42%452K | 78.40%223K | -198.29%-3.09M | -230.82%-3.64M | 37.22%247K |
| Special income (charges) | 59.87%-1.71M | 54.03%-4.25M | ||||||||
| Less:Write off | ---- | ---- | -51.90%1.71M | ---- | ---- | ---- | ---- | -61.65%3.55M | ---- | ---- |
| Less:Negative goodwill immediately recognized | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --704.27K | ---- | ---- |
| Other non-operating income (expenses) | 2.12%-85.28M | -6,323.52%-87.13M | ||||||||
| Income before tax | -153.98%-251K | -245.90%-836K | -22.38%-3.22M | -58.17%-3.99M | -87.47%108K | 280.93%465K | 190.52%573K | 49.38%-2.64M | 62.27%-2.52M | 5,846.67%862K |
| Income tax | -44.08%189K | -46.18%155K | -34.76%435.44K | -139.58%-112K | 265.45%182K | 57.94%338K | 2.86%288K | -25.14%667.44K | 416.52%283K | -173.33%-110K |
| Net income | -446.46%-440K | -447.72%-991K | -10.83%-3.66M | -38.22%-3.88M | -107.61%-74K | 126.96%127K | 131.22%285K | 45.84%-3.3M | 57.47%-2.81M | 689.09%972K |
| Net income continuous operations | -446.46%-440K | -447.72%-991K | -10.83%-3.66M | -38.22%-3.88M | -107.61%-74K | 126.96%127K | 131.22%285K | 45.84%-3.3M | 57.47%-2.81M | 689.09%972K |
| Noncontrolling interests | -233.33%-150K | -404.40%-277K | -383.87%-1.65M | -295.79%-1.72M | -77.88%25K | 83.75%-45K | 168.94%91K | 113.48%581.86K | 125.55%879K | 124.41%113K |
| Net income attributable to the company | -268.60%-290K | -468.04%-714K | 48.29%-2.01M | 41.48%-2.16M | -111.53%-99K | 188.66%172K | 124.84%194K | -118.02%-3.88M | -16.74%-3.68M | 188.26%859K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -268.60%-290K | -468.04%-714K | 48.29%-2.01M | 41.48%-2.16M | -111.53%-99K | 188.66%172K | 124.84%194K | -118.02%-3.88M | -16.74%-3.68M | 188.26%859K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -263.64%-0.0036 | -475.00%-0.009 | 48.26%-0.0253 | 41.47%-0.0271 | -108.33%-0.0009 | 191.67%0.0022 | 124.49%0.0024 | -118.30%-0.0489 | -16.62%-0.0463 | 191.89%0.0108 |
| Diluted earnings per share | -263.64%-0.0036 | -475.00%-0.009 | 48.26%-0.0253 | 41.47%-0.0271 | -108.33%-0.0009 | 191.67%0.0022 | 124.49%0.0024 | -118.30%-0.0489 | -16.62%-0.0463 | 191.89%0.0108 |
| Dividend per share | 0 | 0 | 0.00%0.027 | 0 | 0.00%0.027 | 0 | 0 | 0.00%0.027 | 0 | 0.00%0.027 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.